Ars Technica1 min read
To keep drug prices high, pharma has been piling up the patents
Add-on patents have increased drug patent periods from two years to over six.
By Beth MoleArs Technica
Read the full story
Originally published by Ars Technica on Sep 28, 2026.
Comments
Sign in to join the discussion.